How is Canakinumab dosed?
The dosage of canakinumab subcutaneous route varies depending on the condition being treated. It is typically administered every 8 weeks for CAPS and every 4 weeks for TRAPS, HIDS/MKD, FMF, adult-onset Still's disease, and SJIA.
What is the dosage form of Canakinumab?
Canakinumab subcutaneous route is administered as an injection. It is given by a healthcare professional in a hospital or clinic setting.
How is Canakinumab administered?
Canakinumab subcutaneous route is administered by injecting it under the skin. The injection site may vary, but it is commonly given in the abdomen, thigh, or upper arm. It is important to follow the instructions provided by your healthcare provider and the Medication Guide for proper administration and dosage.
What are common precautions when taking Canakinumab?
When taking canakinumab subcutaneous route, it is important to take the following precautions:
- Regular progress checks: Your doctor should monitor your progress regularly to ensure the medication is working effectively.
- Tuberculosis skin test: Before starting treatment, you or your child must undergo a tuberculosis (TB) skin test. Inform your doctor if anyone in your home has had a positive TB test reaction.
- Reporting side effects: Contact your doctor if you or your child experience fever, chills, cough, hoarseness, lower back or side pain, painful or difficult urination, or any other unusual side effects.
- Increased risk of cancer: Canakinumab may increase the risk of cancer. Discuss the potential risks with your doctor.
- Live vaccinations: Consult your doctor before receiving any vaccinations, especially live vaccines like the nasal flu virus vaccine.
- Macrophage activation syndrome risk: Canakinumab may cause a life-threatening condition called macrophage activation syndrome. Inform your doctor immediately if you or your child experience symptoms such as fever lasting longer than 3 days, a persistent cough, redness in one area of the body, or worsening symptoms of adult-onset Still's disease or systemic juvenile idiopathic arthritis.